Search

AdAlta (ASX: 1AD)

AdAlta (ASX: 1AD)

The Pulse Check

+1

The moment that Chinese biotechs went from 'too hard' to 'too hard to ignore'

Jan 15, 2026

•

11 min read

The moment that Chinese biotechs went from 'too hard' to 'too hard to ignore'

Jason Segal

The Armchair Analyst

The Armchair Analyst Media Pty Ltd ABN 85695734797 is an authorised representative (AR #001322142) of LeMessurier Securities Pty Ltd (LemSec) ABN 43111931 849 (AFSL #296877).

© 2026 The Armchair Analyst.

Powered by beehiiv